The Effects of Taurine, Taurine Homologs and Hypotaurine on Cell and Membrane Antioxidative System Alterations Caused by Type 2 Diabetes in Rat Erythrocytes
This study compared taurine, aminomethanesulfonic acid, homotaurine and hypotaurine for the ability to modify indices of oxidative stress and membrane damage associated with type 2 diabetes. In the study, male Goto-Kakizaki and Wistar-Kyoto rats were allowed free access to a high fat and normal diet, respectively, for 9 weeks. At the end of week 8, half of the animals in each group received a daily intraperitoneal dose of a sulfur compound (0.612 M/kg) for 5 days and, 24 hr after the last treatment, blood samples were withdrawn by cardiac puncture to obtain plasma and erythrocyte fractions for biochemical analyses. Relative to control values, taurine and its congeners reduced membrane damage, the formation of intracellular malondialdehyde and oxidized glutathione, and the decreases in reduced glutathione and antioxidative enzyme activities in diabetic erythrocytes. Except for a few isolated instances, all test compounds were equiprotective.
KeywordsSulfur Compound Vanadyl Sulfate Normal RBCs Exogenous Oxidant Diabetic Erythrocyte
Unable to display preview. Download preview PDF.
- Aruoma OI, Halliwell B, Hoey BM, Butler J (1988) The antioxidant action of taurine, hypotaurine and their metabolic precursors Biochem J 256:251–255Google Scholar
- Fellman JH, Roth ES (1985) The biological oxidation of hypotaurine to taurine: hypotaurine as an antioxidant. In: Oja SS, Ahtee L, Kontro P, Paasonen MK (eds) Taurine: biological actions and clinical perspectives, Alan R. Liss, New York, pp 71–82Google Scholar
- Gallou G, Ruelland A, Campion L, Maugendre D, Le Moullec N, Legras B, Allannic H, Cloarec L (1994) Increase in thiobarbituric acid-reactive substances and vascular complications in type 2 diabetes mellitus Diabetes Metab 20:258–264Google Scholar
- Huxtable RJ (1992) Physiological actions of taurine. Pharmacol Rev 72:101–163Google Scholar
- Ogasawara M, Nakamura T, Koyama I, Nemoto M, Yoshida T (1994) Reactivity of taurine with aldehydes and its physiological role. In: Huxtable R, Michalk DV (eds) Taurine in health and disease, Plenum Press, New York, pp 71–78Google Scholar
- Pitari G,Dupre S, Sprinto A, Antoni G (2000) Hypotaurine protection on cell damage by singlet oxygen. In: Della Corte L, Huxtable RJ, Sgaragli G, Tipton KF (eds) Taurine 4: taurine and excitable tissues, Kluwer Academic/Plenum Publishers, New York, pp 157–162Google Scholar
- Pokhrel KP, Lau-Cam C.A (2000) In vitro and in vivo effects of taurine and structurally related sulfur-containing compounds against phenylhydrazine-induced oxidative damage to erythrocytes. In: Della Corte L, Huxtable RJ, Sgaragli G, Tipton KF (eds) Taurine 4: taurine and excitable tissues, Kluwer Academic/Plenum Publishers, New York, pp 503–522Google Scholar
- Schaffer SW, Azuma J (1992) Myocardial physiological effects of taurine and their significance. In: Lombardini JB, Schaffer SW, Azuma J (eds) Taurine: nutritional value and mechanisms of action, Plenum Press, New York, pp 105–120Google Scholar